IMM 13.2% 29.5¢ immutep limited

News: IMM Immutep Receives Positive EMA Scientific Advice For Further Clinical Development Of EFTI..., page-24

  1. 5,264 Posts.
    lightbulb Created with Sketch. 1642
    In my opinion, which is only a guess, albiet educated guess, planning for AIPAC PhIII is more than likely already on track, including consideration of likely partner candidates, let alone partnership in general. This guess is based on the fact that the team has a very good understanding of what PhIII involves and very very likely they have made preparations. The extent of preparations will be reflected in the timing of announcements to follow post-data release next week.
    Last edited by tuts: 02/11/21
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.